Highlights and Quick Summary
- Non-current Revenue (Deferred) for the quarter ending September 30, 2020 was $0 (a NaN% decrease compared to previous quarter)
Visit stockrow.com/DSGN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Non-current Revenue (Deferred) of Design Therapeutics, Inc.
Most recent Non-current Revenue (Deferred)of DSGN including historical data for past 10 years.Interactive Chart of Non-current Revenue (Deferred) of Design Therapeutics, Inc.
Design Therapeutics, Inc. Non-current Revenue (Deferred) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2020 | $0.0 | $0.0 | $0.0 | – | – |
Business Profile of Design Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology